+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Medical 3D Printing Biomaterials Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283164
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Medical 3D Printing Biomaterials: Executive Overview

Medical 3D printing biomaterials combine additive manufacturing with materials designed for clinical, dental, research, and regenerative applications. Relevant material classes include polymers, ceramics, metals, hydrogels, bioinks, and composite systems. Adoption is shaped by biocompatibility, sterilization compatibility, printability, mechanical performance, degradation behavior, workflow integration, and regulatory evidence. The field is moving from prototype-oriented use toward more controlled production and patient-specific applications, while validation, reproducibility, and clinical adoption remain central requirements.

From Prototyping to Validated Clinical Workflows

The landscape is shifting toward application-specific materials, digitally controlled production, and stronger integration between imaging, design, printing, post-processing, and quality assurance. Hospitals, laboratories, and manufacturers are placing greater emphasis on traceability, repeatability, material characterization, and compatibility with established clinical workflows. At the same time, advances in biofabrication and tissue engineering are expanding research interest in scaffolds, cell-laden bioinks, and resorbable constructs. Progress remains uneven because safety testing, long-term performance, sterilization, reimbursement, and regulatory classification differ by application and jurisdiction.

Artificial Intelligence Improves Design, Process Control, and Material Discovery

Artificial intelligence is contributing to medical 3D printing biomaterials by supporting image segmentation, patient-specific design, topology optimization, process-parameter selection, defect detection, and predictive material characterization. Machine-learning methods can help relate formulation and printing conditions to properties such as porosity, strength, degradation, and biological response. Their value depends on representative datasets, standardized test methods, explainability, cybersecurity, and human oversight. AI does not remove the need for biocompatibility assessment or clinical validation; instead, it can shorten iterative development when embedded within a controlled quality system.

Regional Dynamics Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America benefits from substantial biomedical research capacity, advanced healthcare infrastructure, and established additive-manufacturing expertise, although regulatory and reimbursement requirements influence clinical scaling. Europe emphasizes harmonized safety expectations, research collaboration, and hospital-based innovation, with implementation shaped by national health systems. Asia-Pacific combines strong manufacturing capabilities, expanding healthcare demand, and active research in biomaterials and biofabrication, while regulatory maturity varies across markets. Latin America is developing capabilities through academic centers, dental applications, and localized medical-device production, but access to specialized equipment and validation resources can be uneven. The Middle East is investing in advanced healthcare and localized manufacturing, particularly through innovation hubs and tertiary-care institutions. Africa shows growing research and clinical interest, with adoption influenced by infrastructure, training, supply-chain reliability, and access to validated materials.

Strategic Group Insights: ASEAN, BRICS, European Union, G7, GCC, and NATO

ASEAN countries present a varied combination of manufacturing capacity, medical research, and healthcare access, creating opportunities for regional partnerships and localized training. BRICS members encompass major research, industrial, and healthcare systems, but differ in regulatory approaches, infrastructure, and access to advanced biomaterials. The European Union benefits from cross-border research networks and coordinated policy frameworks, while national implementation and procurement practices still matter. G7 economies generally have mature research ecosystems, sophisticated clinical infrastructure, and demanding evidence requirements. GCC members are strengthening healthcare technology capabilities through investment, specialist institutions, and localization initiatives. NATO members collectively include extensive biomedical research and industrial capacity, though medical-device rules and procurement remain nationally or regionally administered rather than uniform across the group.

Country Perspectives Across Fifteen Priority Markets

Australia combines strong biomedical research with geographically dispersed healthcare delivery, making validated and efficient production workflows important. Brazil has broad clinical needs and active research communities, while infrastructure and regulatory execution can vary by application. Canada brings advanced research institutions and a publicly oriented healthcare environment. China has substantial manufacturing and research capabilities, with increasing attention to domestic innovation and regulatory oversight. France, Germany, Italy, Spain, and the United Kingdom have established biomedical and engineering ecosystems, but adoption is influenced by national reimbursement, procurement, and compliance pathways. India combines a large healthcare need with expanding engineering and biotechnology capabilities, alongside variation in access and validation capacity. Japan emphasizes precision manufacturing, quality, and aging-related healthcare applications. South Korea has strong electronics, medical-device, and biotechnology capabilities supporting digital production. Mexico is developing additive-manufacturing and healthcare innovation capacity, with opportunities linked to dental, surgical, and localized production use cases. Russia maintains scientific and engineering expertise, while availability of equipment, materials, and international collaboration can affect implementation. The United States has extensive clinical research, advanced manufacturing, and regulatory experience, but translation from research to routine care still requires robust evidence, workflow integration, and reimbursement alignment.

Actions for Leaders: Validate Materials, Integrate Workflows, and Govern AI

Industry leaders should define material specifications around the intended clinical use rather than treating printability as the primary criterion. They should establish documented controls for raw-material sourcing, formulation, storage, printing, sterilization, post-processing, and final inspection, supported by traceability and reproducible test methods. Partnerships among clinicians, materials scientists, device engineers, and regulators can improve study design and reduce translation gaps. Organizations adopting AI should maintain data governance, model validation, monitoring, cybersecurity, and clear accountability for clinical decisions. Leaders should also prioritize applications with measurable clinical value, build reimbursement and procurement evidence early, and develop regional strategies that reflect local regulatory, infrastructure, and training conditions.

Methodology: Evidence-Based Synthesis of Medical 3D Printing Biomaterials

This executive summary uses a structured qualitative synthesis of the medical 3D printing biomaterials domain. The assessment considers material classes, additive-manufacturing processes, clinical and research applications, biocompatibility, mechanical and degradation behavior, sterilization, quality systems, regulatory considerations, digital workflows, and artificial-intelligence use. Regional, group, and country perspectives are integrated by examining research capacity, healthcare infrastructure, manufacturing capability, policy environment, workforce readiness, and implementation constraints. Claims are limited to established sector characteristics and observable development patterns; no estimates, market sizing, market shares, or forecasts are used.

Conclusion: Clinical Value Depends on Reproducibility and Evidence

Medical 3D printing biomaterials are progressing through the combined development of advanced formulations, digital manufacturing, biofabrication, and data-driven process control. The strongest long-term opportunities are likely to emerge where materials performance, patient need, production consistency, regulatory evidence, and clinical workflow fit are addressed together. Regional and country conditions will continue to shape adoption, making adaptable partnerships and quality systems essential. Artificial intelligence can accelerate design and monitoring, but trustworthy implementation depends on validated data, transparent governance, and sustained clinical oversight.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical 3D Printing Biomaterials Market, by Material Type
7.1. Introduction
7.2. Biodegradable Polymers
7.2.1. PLA
7.2.2. PCL
7.2.3. PGA
7.3. Hydrogels & Bioinks
7.4. Metals & Metal Alloys
7.4.1. Titanium
7.4.2. Stainless Steel
7.5. Ceramics & Bio-Ceramics
8. Medical 3D Printing Biomaterials Market, by 3D Printing Technology
8.1. Introduction
8.2. Fused Deposition Modeling (FDM)
8.3. Stereolithography (SLA) / Digital Light Processing (DLP)
9. Medical 3D Printing Biomaterials Market, by Biocompatibility
9.1. Introduction
9.2. Permanent / Non-Degradable Materials
9.3. Biodegradable / Absorbable Materials
10. Medical 3D Printing Biomaterials Market, by Application
10.1. Introduction
10.2. Tissue Engineering & Regenerative Medicine
10.3. Bone & Cartilage Implants
10.4. Surgical Models & Guides
11. Medical 3D Printing Biomaterials Market, by End User
11.1. Introduction
11.2. Hospitals & Clinics
11.3. Research & Academic Institutes
11.4. Medical Device Manufacturers
12. Medical 3D Printing Biomaterials Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medical 3D Printing Biomaterials Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medical 3D Printing Biomaterials Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. 3D Systems Corporation
16.2. Arkema Group
16.3. Aspect Biosystems Ltd.
16.4. BICO Group AB
16.5. Concept Laser GmbH
16.6. Cyfuse Biomedical K.K.
16.7. Desktop Metal, Inc.
16.8. EOS GmbH Electro Optical Systems
16.9. Evonik Industries AG
16.10. Formlabs Inc.
16.11. GE Additive
16.12. Höganäs AB
16.13. Materialise NV
16.14. Nano3D Biosciences, Inc.
16.15. Organovo Holdings, Inc.
16.16. RegenHU Ltd.
16.17. Renishaw plc
16.18. Royal DSM
16.19. Solvay S.A.
16.20. Stratasys Ltd.
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Medical 3D Printing Biomaterials Market, Years Considered for the Study
FIGURE 2. Global Medical 3D Printing Biomaterials Market, Research Design
FIGURE 3. Global Medical 3D Printing Biomaterials Market, Research Framework
FIGURE 4. Global Medical 3D Printing Biomaterials Market, Data Triangulation
FIGURE 5. Global Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical 3D Printing Biomaterials Market Size, by Material Type, 2025 vs 2032 (%)
FIGURE 7. Global Medical 3D Printing Biomaterials Market Size, by Material Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2025 vs 2032 (%)
FIGURE 9. Global Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2025 vs 2032 (%)
FIGURE 11. Global Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical 3D Printing Biomaterials Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Medical 3D Printing Biomaterials Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical 3D Printing Biomaterials Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Medical 3D Printing Biomaterials Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical 3D Printing Biomaterials Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medical 3D Printing Biomaterials Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medical 3D Printing Biomaterials Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical 3D Printing Biomaterials Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medical 3D Printing Biomaterials Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medical 3D Printing Biomaterials Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Medical 3D Printing Biomaterials Market Segmentation & Coverage
TABLE 2. Global Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 4. Global Biodegradable Polymers Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Biodegradable Polymers Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Biodegradable Polymers Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global PLA Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global PLA Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global PLA Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global PCL Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global PCL Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global PCL Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global PGA Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global PGA Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global PGA Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Hydrogels & Bioinks Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Hydrogels & Bioinks Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Hydrogels & Bioinks Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Metals & Metal Alloys Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Metals & Metal Alloys Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Metals & Metal Alloys Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Titanium Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Titanium Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Titanium Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Stainless Steel Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Stainless Steel Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Stainless Steel Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Ceramics & Bio-Ceramics Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Ceramics & Bio-Ceramics Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Ceramics & Bio-Ceramics Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 32. Global Fused Deposition Modeling (FDM) Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Fused Deposition Modeling (FDM) Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Fused Deposition Modeling (FDM) Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Stereolithography (SLA) / Digital Light Processing (DLP) Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Stereolithography (SLA) / Digital Light Processing (DLP) Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Stereolithography (SLA) / Digital Light Processing (DLP) Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 39. Global Permanent / Non-Degradable Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Permanent / Non-Degradable Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Permanent / Non-Degradable Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Biodegradable / Absorbable Materials Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Biodegradable / Absorbable Materials Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Biodegradable / Absorbable Materials Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Tissue Engineering & Regenerative Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Tissue Engineering & Regenerative Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Tissue Engineering & Regenerative Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Bone & Cartilage Implants Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Bone & Cartilage Implants Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Bone & Cartilage Implants Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Surgical Models & Guides Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Surgical Models & Guides Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Surgical Models & Guides Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 56. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Research & Academic Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Research & Academic Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Research & Academic Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Medical Device Manufacturers Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Medical Device Manufacturers Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Medical Device Manufacturers Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Medical 3D Printing Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. North America Medical 3D Printing Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. North America Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 76. North America Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 77. North America Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 78. North America Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 79. North America Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 80. North America Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. North America Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 82. Latin America Medical 3D Printing Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Latin America Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 84. Latin America Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 85. Latin America Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 86. Latin America Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 87. Latin America Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 88. Latin America Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. Latin America Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Europe Medical 3D Printing Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Europe Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 92. Europe Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 93. Europe Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 94. Europe Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 95. Europe Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 96. Europe Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 97. Europe Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 98. Middle East Medical 3D Printing Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Middle East Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 100. Middle East Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 101. Middle East Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 102. Middle East Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 103. Middle East Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 104. Middle East Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. Middle East Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 106. Africa Medical 3D Printing Biomaterials Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Africa Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 108. Africa Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 109. Africa Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 110. Africa Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 111. Africa Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 112. Africa Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Africa Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Global Medical 3D Printing Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. ASEAN Medical 3D Printing Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 117. ASEAN Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 118. ASEAN Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 119. ASEAN Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 120. ASEAN Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 121. ASEAN Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. ASEAN Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. GCC Medical 3D Printing Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. GCC Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 125. GCC Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 126. GCC Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 127. GCC Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 128. GCC Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 129. GCC Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. GCC Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. European Union Medical 3D Printing Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. European Union Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 133. European Union Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 134. European Union Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 135. European Union Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 136. European Union Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 137. European Union Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. European Union Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 139. BRICS Medical 3D Printing Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. BRICS Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 141. BRICS Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 142. BRICS Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 143. BRICS Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 144. BRICS Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 145. BRICS Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 146. BRICS Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. G7 Medical 3D Printing Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. G7 Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 149. G7 Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 150. G7 Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 151. G7 Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 152. G7 Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 153. G7 Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. G7 Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. NATO Medical 3D Printing Biomaterials Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. NATO Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 157. NATO Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 158. NATO Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 159. NATO Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 160. NATO Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 161. NATO Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. NATO Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. Global Medical 3D Printing Biomaterials Market Size, by Country, 2017-2032 (USD Million)
TABLE 164. United States Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 165. United States Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 166. United States Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 167. United States Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 168. United States Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 169. United States Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 170. United States Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. United States Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Canada Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 173. Canada Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 174. Canada Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 175. Canada Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 176. Canada Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 177. Canada Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 178. Canada Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Canada Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. Mexico Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 181. Mexico Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 182. Mexico Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 183. Mexico Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 184. Mexico Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 185. Mexico Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 186. Mexico Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 187. Mexico Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Brazil Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 189. Brazil Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 190. Brazil Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 191. Brazil Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 192. Brazil Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 193. Brazil Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 194. Brazil Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. Brazil Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. United Kingdom Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 197. United Kingdom Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 198. United Kingdom Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 199. United Kingdom Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 200. United Kingdom Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 201. United Kingdom Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 202. United Kingdom Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. United Kingdom Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 204. Germany Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 205. Germany Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 206. Germany Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 207. Germany Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 208. Germany Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 209. Germany Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 210. Germany Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. Germany Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. France Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 213. France Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 214. France Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 215. France Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 216. France Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 217. France Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 218. France Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 219. France Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Russia Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 221. Russia Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 222. Russia Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 223. Russia Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 224. Russia Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 225. Russia Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 226. Russia Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Russia Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Italy Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 229. Italy Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 230. Italy Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 231. Italy Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 232. Italy Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 233. Italy Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 234. Italy Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 235. Italy Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Spain Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 237. Spain Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 238. Spain Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 239. Spain Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 240. Spain Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 241. Spain Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 242. Spain Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 243. Spain Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. China Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 245. China Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 246. China Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 247. China Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 248. China Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 249. China Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 250. China Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. China Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. India Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 253. India Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 254. India Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 255. India Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 256. India Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 257. India Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 258. India Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 259. India Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 260. Japan Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 261. Japan Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 262. Japan Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 263. Japan Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 264. Japan Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 265. Japan Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 266. Japan Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Japan Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Australia Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 269. Australia Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 270. Australia Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 271. Australia Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 272. Australia Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 273. Australia Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 274. Australia Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Australia Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. South Korea Medical 3D Printing Biomaterials Market Size, 2017-2032 (USD Million)
TABLE 277. South Korea Medical 3D Printing Biomaterials Market Size, by Material Type, 2017-2032 (USD Million)
TABLE 278. South Korea Medical 3D Printing Biomaterials Market Size, by Biodegradable Polymers, 2017-2032 (USD Million)
TABLE 279. South Korea Medical 3D Printing Biomaterials Market Size, by Metals & Metal Alloys, 2017-2032 (USD Million)
TABLE 280. South Korea Medical 3D Printing Biomaterials Market Size, by 3D Printing Technology, 2017-2032 (USD Million)
TABLE 281. South Korea Medical 3D Printing Biomaterials Market Size, by Biocompatibility, 2017-2032 (USD Million)
TABLE 282. South Korea Medical 3D Printing Biomaterials Market Size, by Application, 2017-2032 (USD Million)
TABLE 283. South Korea Medical 3D Printing Biomaterials Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. Global Medical 3D Printing Biomaterials Market Share, by Key Player, 2025
TABLE 285. Global Medical 3D Printing Biomaterials Market, Key Experts

Companies Mentioned

  • 3D Systems Corporation
  • Arkema Group
  • Aspect Biosystems Ltd.
  • BICO Group AB
  • Concept Laser GmbH
  • Cyfuse Biomedical K.K.
  • Desktop Metal, Inc.
  • EOS GmbH Electro Optical Systems
  • Evonik Industries AG
  • Formlabs Inc.
  • GE Additive
  • Höganäs AB
  • Materialise NV
  • Nano3D Biosciences, Inc.
  • Organovo Holdings, Inc.
  • RegenHU Ltd.
  • Renishaw plc
  • Royal DSM
  • Solvay S.A.
  • Stratasys Ltd.